Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997
Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997
Reversible MRI Findings in a Patient with Hashimoto's Encephalopathy
Neurol 49:246-247, Bohnen,N.I.L.J.,et al, 1997
Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997
Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997
Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997
Autoantibodies to Glutamic Acid Decarboxylase in Three Patients With Cerebellar Ataxia, Late-Onset Insulin-Dependent Diabetes Mellitus, and Polyendocrine Autoimmunity
Neurol 49:1026-1030, Saiz,A.,et al, 1997
A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996
Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996
Paraneoplastic Limbic Encephalitis in Hodgkin's Disease
Can J Neurol Sci 23:138-140, Deodhare,S.,et al, 1996
Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996
Total Alopecia, Diabetes Mellitus, and Falls
Lancet 348:1420, Mueller-Schoop,J.W., 1996
Use of Sumatriptan in Post-Ictal Migraine Headache
Neurol 47:1104, Jacob,J.,et al, 1996
Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996
Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996
A Woman with a Relapsing Psychosis Who Got Better with Prednisone
Lancet 347:1288, Cohen,L.,et al, 1996
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996
Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996
Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996
Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996
The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995
Oral Sumatriptan-Associated Transmural Myocardial Infarction
Neurol 45:2274-2276, O'Connor,P.&Gladstone,P., 1995
The Poisoned Patient with Altered Consciousness, Controversies in the Use of a"Coma Cocktail"
JAMA 274:562-569, Hoffman,R.S.&Goldfrank,L.R., 1995
Electroencephalographic Findings in Hashimoto's Encephalopathy
Neurol 45:977-981, Henchey,R.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995
The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995
Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995
Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995
Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995
Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995
Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995
Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995
Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995
Clinical Experience with Excitatory Amino Acid Antagonist Drugs
Stroke 26:503-513, Muir,K.W.&Lees,K.R., 1995
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Analgesic Headache
BMJ 310:479-480, Olesen,J., 1995
Drugs for Migraine
The Medical Letter 37:17-20, , 1995
Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995